The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor

(2010) Douglas McHugh et al.   BMC NEUROSCIENCE

An introduction to the endocannabinoid system: from the early to the latest concepts

(2009) Luciano De Petrocellis et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis

(2009) Martin A. Storr et al.   INFLAMMATORY BOWEL DISEASES

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

(2009) Francesca Borrelli et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

CB1 Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents

(2009) M. Brusberg et al.   JOURNAL OF NEUROSCIENCE

Therapeutic Effect of Blocking CXCR2 on Neutrophil Recruitment and Dextran Sodium Sulfate-Induced Colitis

(2009) S. M. Farooq et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Cannabinoids in intestinal inflammation and cancer

(2009) Angelo A. Izzo et al.   PHARMACOLOGICAL RESEARCH

The therapeutic potential of novel cannabinoid receptors

(2009) Faith R. Kreitzer et al.   PHARMACOLOGY & THERAPEUTICS

The enigmatic pharmacology of GPR55

(2009) Ruth A. Ross   TRENDS IN PHARMACOLOGICAL SCIENCES

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

(2009) Angelo A. Izzo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Accumulation, activation, and survival of neutrophils in ulcerative colitis: regulation by locally produced factors in the colon and impact of steroid treatment

(2008) Maria Lampinen et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression

(2008) M. Waldeck-Weiermair et al.   JOURNAL OF CELL SCIENCE

The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice

(2008) Allisson Freire Bento et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors

(2008) Martin A. Storr et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

(2008) Penny C. Staton et al.   PAIN

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

(2008) J. E. Lauckner et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

Novel cannabinoid receptors

(2007) A J Brown   BRITISH JOURNAL OF PHARMACOLOGY

Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain

(2007) M D Jhaveri et al.   BRITISH JOURNAL OF PHARMACOLOGY

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

(2007) D G Johns et al.   BRITISH JOURNAL OF PHARMACOLOGY

The orphan receptor GPR55 is a novel cannabinoid receptor

(2007) E Ryberg et al.   BRITISH JOURNAL OF PHARMACOLOGY